• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, September 20, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

JAX receives NIH grant to improve CRISPR-Cas9 accuracy

Bioengineer by Bioengineer
March 1, 2017
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A two-year grant totaling $455,000 from the National Institutes of Health to Michael V. Wiles, Ph.D., senior director of Technology Evaluation and Development at The Jackson Laboratory, will support research to improve the accuracy and efficiency of genome editing for research, drug testing and future therapeutic delivery.

The technology known as CRISPR-Cas9 has revolutionized scientists' ability to edit the genomes of plants and animals, including mice and humans, to study and manipulate the genome. However, the promise of consistent and reproducible therapeutic delivery of modifications to the genome faces technical obstacles, particularly when researchers attempt to insert relatively long segments of DNA into a genome.

Harnessing a precise natural process of DNA repair (known as homology directed repair or HDR) is vital for achieving a perfect, seamless replacement of a faulty gene within its native environment. CRISPR-Cas9 experiments in mice show that HDR doesn't always as efficiently as needed, and the current processes for screening mice for correctly edited DNA are time-consuming, laborious and expensive.

Wiles and his team are developing rigorous testing regimes to determine which processes and techniques lead to the highest accurate editing rates in the gene-editing process in mouse embryos.

"The broad goal of this work," Wiles says, "is to significantly improve the reliability and efficiency of targeted nuclease-mediated HDR by developing and validating a high-throughput, low-cost approach capable of testing multiple variables for targeting HDR directly in mouse zygotes, and making this information publicly available" to the research community.

###

The Jackson Laboratory is an independent, nonprofit biomedical research institution based in Bar Harbor, Maine, with a National Cancer Institute-designated Cancer Center, a facility in Sacramento, Calif., and a genomic medicine institute in Farmington, Conn. It employs 1,900 staff, and its mission is to discover precise genomic solutions for disease and empower the global biomedical community in the shared quest to improve human health.

Media Contact

Sarah Laskowski
[email protected]
860-837-2102
@jacksonlab

http://www.jax.org

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

Hydrocortisone Use in Extremely Preterm Infants

September 20, 2025

Standardized Extract Boosts Immunity in Chemotherapy Mice

September 20, 2025

Reticulocalbin-1: Biomarker and Therapy Target in RCC

September 20, 2025

Ag-Doped MnO2 Sea Urchin Structure Boosts Zinc Batteries

September 20, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    156 shares
    Share 62 Tweet 39
  • Physicists Develop Visible Time Crystal for the First Time

    67 shares
    Share 27 Tweet 17
  • Tailored Gene-Editing Technology Emerges as a Promising Treatment for Fatal Pediatric Diseases

    49 shares
    Share 20 Tweet 12
  • Scientists Achieve Ambient-Temperature Light-Induced Heterolytic Hydrogen Dissociation

    48 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Hydrocortisone Use in Extremely Preterm Infants

Standardized Extract Boosts Immunity in Chemotherapy Mice

Reticulocalbin-1: Biomarker and Therapy Target in RCC

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.